enow.com Web Search

  1. Ads

    related to: diabetes medication selection chart

Search results

  1. Results from the WOW.Com Content Network
  2. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    There are different classes of hypoglycemic drugs, and selection of the appropriate agent depends on the nature of diabetes, age, and situation of the person, as well as other patient factors. Type 1 diabetes is a disease caused by the lack of insulin. Thus, insulin is the main treatment agent for type 1 and is typically administered via ...

  3. ATC code A10 - Wikipedia

    en.wikipedia.org/wiki/ATC_code_A10

    ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup A10 is part of the anatomical group A Alimentary tract and ...

  4. Category:Anti-diabetic drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Anti-diabetic_drugs

    Generally, drugs outlined within the ATC code A10 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Anti-diabetic drugs .

  5. Diabetes management - Wikipedia

    en.wikipedia.org/wiki/Diabetes_management

    The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]

  6. Insulin degludec/liraglutide - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec/liraglutide

    Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination with diet and exercise. [7] [8] It contains insulin degludec and liraglutide. [7] [8] It is administered by subcutaneous injection. [7] [8]

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  1. Ads

    related to: diabetes medication selection chart